• August 8, 2017
    PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today reported its financial results for the second quarter of 2017 and increased its full year guidance for revenue and net income. The company reported revenue of $1.3 billion for the second quarter of 2017, an increase of 5% compared with the second quarter of 2016. Net income for the second quarter of 2017 was $247 million, or $0.50 per diluted share, an increase of 10% and 11%, respectively, on amore...
  • August 3, 2017
    PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) today announced the appointment of Dr. Linda Rhodes, an accomplished scientist, academic, veterinarian and business leader in animal health, to its Board of Directors. Her appointment is effective at the close of business today, and she will serve on the Quality and Innovation Committee of the Board. “I am very pleased to welcome Dr. Rhodes to the Zoetis Board of Directors,” said Zoetis Chief Executivemore...
  • July 31, 2017
    PARSIPPANY, N.J. & TULLAMORE, Ireland--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) and Nexvet Biopharma plc (Nasdaq:NVET) today announced that Zoetis has completed the acquisition of Nexvet, a biologic therapeutics company developing a pipeline of monoclonal antibody (mAb) therapies for companion animals in pain and other therapeutic areas. The acquisition, which was first announced on April 13, 2017, strengthens Zoetis’ pipeline of solutions for chronic pain management in dogs and cats. Itmore...
  • June 30, 2017
    PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, August 8, 2017. Chief Executive Officer Juan Ramón Alaix and Executive Vice President and Chief Financial Officer Glenn David will review second quarter 2017 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live webcast by visiting the Zoetis website at http://more...
  • June 16, 2017
    PARSIPPANY, N.J.--(BUSINESS WIRE)--NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. FOR IMMEDIATE RELEASE June 16, 2017 Recommended Acquisition for Cash by ZOETIS BELGIUM S.A. A WHOLLY-OWNED INDIRECT SUBSIDIARY OF ZOETIS INC. ofmore...
  • June 1, 2017
    PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the William Blair Growth Stock Conference on Tuesday, June 13, 2017, in Chicago, Ill. Juan Ramón Alaix, Chief Executive Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 3:10 p.m. ET (2:10 p.m. CT). Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.more...
  • May 25, 2017
    PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2017 Dental and Veterinary Conference on Wednesday, May 31, 2017, in New York, N.Y. Kristin Peck, Executive Vice President and President, U.S. Operations, will represent the company and respond to questions from analysts. She is scheduled to present at 3:00 p.m. ET. Investors and other interested parties will be able to access a live audio webcast of the presentation bymore...
  • May 11, 2017
    PARSIPPANY, N.J.--(BUSINESS WIRE)--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a third quarter 2017 dividend payable to holders of the company’s common stock of $0.105 per share. The dividend is to be paid on Friday, Sept. 1, 2017, to holders of record on Thursday, June 15, 2017. About Zoetis Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years ofmore...
  • May 11, 2017
    SHORT HILLS, N.J.--(BUSINESS WIRE)--Speaking to shareholders at the Zoetis Inc. (NYSE:ZTS) annual meeting today in Short Hills, N.J., Chief Executive Officer Juan Ramón Alaix discussed the company’s 2016 performance and strategies for continued growth as the leader in the global animal health industry. “In 2016, we delivered our fourth consecutive year of operational revenue growth and improved profitability since becoming an independent public company,” said Alaixmore...
  • May 10, 2017
    Zoetis Inc. today announced a plan to expand capacity at its Global Manufacturing and Supply facility in Kalamazoo, Mich.  Zoetis will install two new production lines and related operations to manufacture oral tablet and chewable medicines for companion animals. The company expects to add up to 45 manufacturing positions in the next three years.    “Kalamazoo is home to one of the largest and most important manufacturing sites in Zoetis’ Global Manufacturing and Supplymore...